AW, S. (2026). Optimizing the Clinical Exposure of Fosfomycin in Critically Ill Adult Septic Patients: A Physiologically Based Pharmacokinetic Modeling. Therapeutic drug monitoring, 48(4), 497. https://doi.org/10.1097/FTD.0000000000001423
Chicago Style (17th ed.) CitationAW, Sherazi. "Optimizing the Clinical Exposure of Fosfomycin in Critically Ill Adult Septic Patients: A Physiologically Based Pharmacokinetic Modeling." Therapeutic Drug Monitoring 48, no. 4 (2026): 497. https://doi.org/10.1097/FTD.0000000000001423.
MLA (9th ed.) CitationAW, Sherazi. "Optimizing the Clinical Exposure of Fosfomycin in Critically Ill Adult Septic Patients: A Physiologically Based Pharmacokinetic Modeling." Therapeutic Drug Monitoring, vol. 48, no. 4, 2026, p. 497, https://doi.org/10.1097/FTD.0000000000001423.